Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia

Shirin Biglari, Alfizah Hanafiah, Shaliawani Mohd Puzi, Ramliza Ramli, Mostafizur Rahman, Bruno Silvester Lopes

Research output: Contribution to journalArticle

7 Citations (Scopus)
17 Downloads (Pure)

Abstract

Multidrug-resistant (MDR) Acinetobacter baumannii has increasingly emerged as an important nosocomial pathogen. The aim of this study was to determine the resistance profiles and genetic diversity in A. baumannii clinical isolates in a tertiary medical center in Malaysia. The minimum inhibitory concentrations of carbapenems (imipenem and meropenem), cephalosporins (ceftazidime and cefepime), and ciprofloxacin were determined by E-test. PCR and sequencing were carried out for the detection of antibiotic resistance genes and mutations. Clonal relatedness among A. baumannii isolates was determined by REP-PCR. Sequence-based typing of OXA-51 and multilocus sequence typing were performed. One hundred twenty-five of 162 (77.2%) A. baumannii isolates had MDR phenotype. From the 162 A. baumannii isolates, 20 strain types were identified and majority of A. baumannii isolates (66%, n = 107) were classified as strain type 1 and were positive for ISAba1-blaOXA-23 and ISAba1-blaADC and had mutations in both gyrA and parC genes at positions, 83 and 80, resulting in serine-to-leucine conversion. REP-PCR analysis showed 129 REP types that generated 31 clones with a 90% similarity cutoff value. OXA-66 variant of the blaOXA-51-like genes was predominantly detected among our A. baumannii clinical isolates belonging to ST195 (found in six clones: 1, 8, 9, 19, 27, and 30) and ST208 (found in clone 21). The study helps us in understanding the genetic diversity of A. baumannii isolates in our setting and confirms that international clone II is the most widely distributed clone in Universiti Kebangsaan Malaysia Medical Centre, Malaysia.

Original languageEnglish
Pages (from-to)545-555
Number of pages11
JournalMicrobial Drug Resistance
Volume23
Issue number5
Early online date17 Nov 2016
DOIs
Publication statusPublished - Jul 2017

Fingerprint

Acinetobacter baumannii
Malaysia
Teaching Hospitals
Clone Cells
meropenem
Polymerase Chain Reaction
Multilocus Sequence Typing
Mutation
Carbapenems
Gene Order
Ceftazidime
Imipenem
Microbial Sensitivity Tests
Cephalosporins
Ciprofloxacin
Microbial Drug Resistance
Leucine
Serine
Genes
Phenotype

Keywords

  • Acinetobacter baumannii
  • multidrug resistance
  • OXA-51
  • sequence typing
  • MLST

Cite this

Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia. / Biglari, Shirin; Hanafiah, Alfizah; Mohd Puzi, Shaliawani; Ramli, Ramliza; Rahman, Mostafizur; Lopes, Bruno Silvester.

In: Microbial Drug Resistance, Vol. 23, No. 5, 07.2017, p. 545-555.

Research output: Contribution to journalArticle

Biglari, Shirin ; Hanafiah, Alfizah ; Mohd Puzi, Shaliawani ; Ramli, Ramliza ; Rahman, Mostafizur ; Lopes, Bruno Silvester. / Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia. In: Microbial Drug Resistance. 2017 ; Vol. 23, No. 5. pp. 545-555.
@article{8533386cb9b148caba572f531fb69b16,
title = "Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia",
abstract = "Multidrug-resistant (MDR) Acinetobacter baumannii has increasingly emerged as an important nosocomial pathogen. The aim of this study was to determine the resistance profiles and genetic diversity in A. baumannii clinical isolates in a tertiary medical center in Malaysia. The minimum inhibitory concentrations of carbapenems (imipenem and meropenem), cephalosporins (ceftazidime and cefepime), and ciprofloxacin were determined by E-test. PCR and sequencing were carried out for the detection of antibiotic resistance genes and mutations. Clonal relatedness among A. baumannii isolates was determined by REP-PCR. Sequence-based typing of OXA-51 and multilocus sequence typing were performed. One hundred twenty-five of 162 (77.2{\%}) A. baumannii isolates had MDR phenotype. From the 162 A. baumannii isolates, 20 strain types were identified and majority of A. baumannii isolates (66{\%}, n = 107) were classified as strain type 1 and were positive for ISAba1-blaOXA-23 and ISAba1-blaADC and had mutations in both gyrA and parC genes at positions, 83 and 80, resulting in serine-to-leucine conversion. REP-PCR analysis showed 129 REP types that generated 31 clones with a 90{\%} similarity cutoff value. OXA-66 variant of the blaOXA-51-like genes was predominantly detected among our A. baumannii clinical isolates belonging to ST195 (found in six clones: 1, 8, 9, 19, 27, and 30) and ST208 (found in clone 21). The study helps us in understanding the genetic diversity of A. baumannii isolates in our setting and confirms that international clone II is the most widely distributed clone in Universiti Kebangsaan Malaysia Medical Centre, Malaysia.",
keywords = "Acinetobacter baumannii, multidrug resistance, OXA-51, sequence typing, MLST",
author = "Shirin Biglari and Alfizah Hanafiah and {Mohd Puzi}, Shaliawani and Ramliza Ramli and Mostafizur Rahman and Lopes, {Bruno Silvester}",
note = "This work is funded by a grant from the Faculty of Medicine, Universiti Kebangsaan Malaysia (Grant No. FF-004-2012). The authors would like to thank the Universiti Kebangsaan Malaysia for providing studentship to S.B. and to the staff at the Department of Medical Microbiology & Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia for their assistance during the study.",
year = "2017",
month = "7",
doi = "10.1089/mdr.2016.0130",
language = "English",
volume = "23",
pages = "545--555",
journal = "Microbial Drug Resistance",
issn = "1076-6294",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia

AU - Biglari, Shirin

AU - Hanafiah, Alfizah

AU - Mohd Puzi, Shaliawani

AU - Ramli, Ramliza

AU - Rahman, Mostafizur

AU - Lopes, Bruno Silvester

N1 - This work is funded by a grant from the Faculty of Medicine, Universiti Kebangsaan Malaysia (Grant No. FF-004-2012). The authors would like to thank the Universiti Kebangsaan Malaysia for providing studentship to S.B. and to the staff at the Department of Medical Microbiology & Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia for their assistance during the study.

PY - 2017/7

Y1 - 2017/7

N2 - Multidrug-resistant (MDR) Acinetobacter baumannii has increasingly emerged as an important nosocomial pathogen. The aim of this study was to determine the resistance profiles and genetic diversity in A. baumannii clinical isolates in a tertiary medical center in Malaysia. The minimum inhibitory concentrations of carbapenems (imipenem and meropenem), cephalosporins (ceftazidime and cefepime), and ciprofloxacin were determined by E-test. PCR and sequencing were carried out for the detection of antibiotic resistance genes and mutations. Clonal relatedness among A. baumannii isolates was determined by REP-PCR. Sequence-based typing of OXA-51 and multilocus sequence typing were performed. One hundred twenty-five of 162 (77.2%) A. baumannii isolates had MDR phenotype. From the 162 A. baumannii isolates, 20 strain types were identified and majority of A. baumannii isolates (66%, n = 107) were classified as strain type 1 and were positive for ISAba1-blaOXA-23 and ISAba1-blaADC and had mutations in both gyrA and parC genes at positions, 83 and 80, resulting in serine-to-leucine conversion. REP-PCR analysis showed 129 REP types that generated 31 clones with a 90% similarity cutoff value. OXA-66 variant of the blaOXA-51-like genes was predominantly detected among our A. baumannii clinical isolates belonging to ST195 (found in six clones: 1, 8, 9, 19, 27, and 30) and ST208 (found in clone 21). The study helps us in understanding the genetic diversity of A. baumannii isolates in our setting and confirms that international clone II is the most widely distributed clone in Universiti Kebangsaan Malaysia Medical Centre, Malaysia.

AB - Multidrug-resistant (MDR) Acinetobacter baumannii has increasingly emerged as an important nosocomial pathogen. The aim of this study was to determine the resistance profiles and genetic diversity in A. baumannii clinical isolates in a tertiary medical center in Malaysia. The minimum inhibitory concentrations of carbapenems (imipenem and meropenem), cephalosporins (ceftazidime and cefepime), and ciprofloxacin were determined by E-test. PCR and sequencing were carried out for the detection of antibiotic resistance genes and mutations. Clonal relatedness among A. baumannii isolates was determined by REP-PCR. Sequence-based typing of OXA-51 and multilocus sequence typing were performed. One hundred twenty-five of 162 (77.2%) A. baumannii isolates had MDR phenotype. From the 162 A. baumannii isolates, 20 strain types were identified and majority of A. baumannii isolates (66%, n = 107) were classified as strain type 1 and were positive for ISAba1-blaOXA-23 and ISAba1-blaADC and had mutations in both gyrA and parC genes at positions, 83 and 80, resulting in serine-to-leucine conversion. REP-PCR analysis showed 129 REP types that generated 31 clones with a 90% similarity cutoff value. OXA-66 variant of the blaOXA-51-like genes was predominantly detected among our A. baumannii clinical isolates belonging to ST195 (found in six clones: 1, 8, 9, 19, 27, and 30) and ST208 (found in clone 21). The study helps us in understanding the genetic diversity of A. baumannii isolates in our setting and confirms that international clone II is the most widely distributed clone in Universiti Kebangsaan Malaysia Medical Centre, Malaysia.

KW - Acinetobacter baumannii

KW - multidrug resistance

KW - OXA-51

KW - sequence typing

KW - MLST

U2 - 10.1089/mdr.2016.0130

DO - 10.1089/mdr.2016.0130

M3 - Article

C2 - 27854165

VL - 23

SP - 545

EP - 555

JO - Microbial Drug Resistance

JF - Microbial Drug Resistance

SN - 1076-6294

IS - 5

ER -